125 related articles for article (PubMed ID: 7915945)
1. Production of interleukin-6 by monocytes isolated from rheumatoid arthritis patients receiving second-line drug therapy.
Crilly A; Madhok R; Watson J; Capell HA; Sturrock RD
Br J Rheumatol; 1994 Sep; 33(9):821-5. PubMed ID: 7915945
[TBL] [Abstract][Full Text] [Related]
2. The effect of gold sodium thiomalate and auranofin on lipopolysaccharide-induced interleukin-1 production by blood monocytes in vitro: variation in healthy subjects and patients with arthritis.
Danis VA; Kulesz AJ; Nelson DS; Brooks PM
Clin Exp Immunol; 1990 Mar; 79(3):335-40. PubMed ID: 2107989
[TBL] [Abstract][Full Text] [Related]
3. Serum concentrations of soluble interleukin 2 receptor in patients with rheumatoid arthritis: effect of second line drugs.
Crilly A; Madhok R; Watson J; Capell HA
Ann Rheum Dis; 1993 Jan; 52(1):58-60. PubMed ID: 8093995
[TBL] [Abstract][Full Text] [Related]
4. Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.
Pullar T; Hunter JA; Capell HA
Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1102-4. PubMed ID: 6138117
[TBL] [Abstract][Full Text] [Related]
5. The effect of auranofin and sulphasalazine therapy on circulating levels of interleukin 6 in rheumatoid arthritis patients.
Crilly A; Capell HA; Watson J; Madhok R
Clin Rheumatol; 1995 Sep; 14(5):561-5. PubMed ID: 8549096
[No Abstract] [Full Text] [Related]
6. [Comparative study of the effects of auranofin and aurothiomalate on laboratory and clinical indicators in patients with rheumatoid arthritis].
Vlak T; Stambuk B
Reumatizam; 1998; 46(1):7-19. PubMed ID: 9921004
[TBL] [Abstract][Full Text] [Related]
7. One-year experience in patients treated with auranofin following completion of a parallel, controlled trial comparing auranofin, gold sodium thiomalate, and placebo.
Williams HJ; Dahl SL; Ward JR; Karg M; Willkens RF; Meenan RF; Altz-Smith M; Clegg DO; Mikkelsen WM; Kay DR
Arthritis Rheum; 1988 Jan; 31(1):9-14. PubMed ID: 3125841
[TBL] [Abstract][Full Text] [Related]
8. IL-6 and soluble IL-2 receptor in rheumatoid arthritis patients treated with second line drugs.
Watson J; Crilly A; Madhok R; Capell H; Sturrock R
Biochem Soc Trans; 1992 May; 20(2):138S. PubMed ID: 1356854
[No Abstract] [Full Text] [Related]
9. Pharmacologic modulation of TNF production by endotoxin stimulated macrophages: in vitro and in vivo effects of auranofin and other chrysotherapeutic compounds.
Evans GF; Zuckerman SH
Agents Actions; 1989 Mar; 26(3-4):329-34. PubMed ID: 2500010
[TBL] [Abstract][Full Text] [Related]
10. A three year follow up of patients allocated to placebo, or oral or injectable gold therapy for rheumatoid arthritis.
Capell HA; Lewis D; Carey J
Ann Rheum Dis; 1986 Sep; 45(9):705-11. PubMed ID: 3094463
[TBL] [Abstract][Full Text] [Related]
11. A three year comparative multicenter study of auranofin (AF) and gold sodium thiomalate (GST) in the treatment of rheumatoid arthritis (RA).
Rau R; Schattenkirchner M; Müller-Fassbender H; Kaik B; Zeidler H
Clin Rheumatol; 1987 Sep; 6 Suppl 2():43-52. PubMed ID: 3121238
[No Abstract] [Full Text] [Related]
12. Synergistic inhibition of human B cell activation by gold sodium thiomalate and auranofin.
Hirohata S; Nakanishi K; Yanagida T; Kawai M; Kikuchi H; Isshi K
Clin Immunol; 1999 May; 91(2):226-33. PubMed ID: 10227815
[TBL] [Abstract][Full Text] [Related]
13. [Well controlled comparative study in early rheumatoid arthritis with gold sodium thiomalate vs. auranofin].
Yamamoto S; Mitomo N; Saito T; Nishioka K; Inoue K; Uchida S; Ohata N; Murasawa A; Suzuki A; Mitsui T
Ryumachi; 1990 Feb; 30(1):26-44. PubMed ID: 2116042
[TBL] [Abstract][Full Text] [Related]
14. Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial.
Ward JR; Williams HJ; Egger MJ; Reading JC; Boyce E; Altz-Smith M; Samuelson CO; Willkens RF; Solsky MA; Hayes SP
Arthritis Rheum; 1983 Nov; 26(11):1303-15. PubMed ID: 6416259
[TBL] [Abstract][Full Text] [Related]
15. Studies of the effect of D-penicillamine and sodium aurothiomalate therapy on superoxide anion production by monocytes from patients with rheumatoid arthritis: evidence for in vivo stimulation of monocytes.
Hurst NP; Bell AL; Nuki G
Ann Rheum Dis; 1986 Jan; 45(1):37-43. PubMed ID: 3006610
[TBL] [Abstract][Full Text] [Related]
16. A three year comparative study of auranofin and gold sodium thiomalate in rheumatoid arthritis.
Rau R; Schattenkirchner M; Muller-Fassbender H; Kaik B; Zeidler H; Missler B
Clin Rheumatol; 1990 Dec; 9(4):461-74. PubMed ID: 2128475
[TBL] [Abstract][Full Text] [Related]
17. Comparison between sodium aurothiomalate and auranofin in rheumatoid arthritis. Results of a two-year open randomized study.
Harth M; Davis P; Thompson JM; Menard H; Beaudet F
Scand J Rheumatol; 1987; 16(3):177-84. PubMed ID: 3110944
[TBL] [Abstract][Full Text] [Related]
18. Erythrocyte membrane gold levels after treatment with auranofin and sodium aurothiomalate.
Iqbal MS; Saeed M; Taqi SG
Biol Trace Elem Res; 2008; 126(1-3):56-64. PubMed ID: 18649049
[TBL] [Abstract][Full Text] [Related]
19. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR
Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711
[TBL] [Abstract][Full Text] [Related]
20. Unique properties of auranofin as a potential anti-rheumatic drug.
Barrett ML; Lewis GP
Agents Actions; 1986 Oct; 19(1-2):109-15. PubMed ID: 3099556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
